The Ontario Ministry of Health and Long-Term Care (the Ministry) has proposed draft amendments to Regulations made under the Ontario Drug Benefit Act (ODBA) and the Ontario Drug Interchangeability and Dispensing Fee Act. The proposed changes are intended to reduce technical requirements for listing a product on the Ontario formulary and align policies with industry … Continue reading
Case: Blake, Cassels & Graydon LLP v United Therapeutics Corporation, 2017 TMOB 9 Trade-Mark: REMODULIN Nature of case: Summary expungement proceedingpursuant to section 45 of Trade-marks Act Successful party: United Therapeutics Corporation Date of decision: January 26, 2017 Summary The Trademarks Opposition Board (TMOB) accepted United Therapeutics Corporation’s evidence of use of the trade-mark REMODULIN … Continue reading